Amoy Diagnostics Co., Ltd.

SZSE:300685 Stock Report

Market Cap: CN¥8.7b

Amoy Diagnostics Management

Management criteria checks 3/4

Amoy Diagnostics' CEO is Jiemin Luo, appointed in Jan 2012, has a tenure of 3.42 years. directly owns 0.039% of the company’s shares, worth CN¥3.35M. The average tenure of the management team and the board of directors is 13 years and 3.4 years respectively.

Key information

Jiemin Luo

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure13yrs
CEO ownership0.04%
Management average tenure13yrs
Board average tenure3.4yrs

Recent management updates

Recent updates

Estimating The Fair Value Of Amoy Diagnostics Co., Ltd. (SZSE:300685)

Jan 07
Estimating The Fair Value Of Amoy Diagnostics Co., Ltd. (SZSE:300685)

Amoy Diagnostics (SZSE:300685) Has A Rock Solid Balance Sheet

Dec 19
Amoy Diagnostics (SZSE:300685) Has A Rock Solid Balance Sheet

Amoy Diagnostics Co., Ltd.'s (SZSE:300685) Earnings Haven't Escaped The Attention Of Investors

Sep 18
Amoy Diagnostics Co., Ltd.'s (SZSE:300685) Earnings Haven't Escaped The Attention Of Investors

Are Investors Undervaluing Amoy Diagnostics Co., Ltd. (SZSE:300685) By 23%?

Aug 23
Are Investors Undervaluing Amoy Diagnostics Co., Ltd. (SZSE:300685) By 23%?

Amoy Diagnostics' (SZSE:300685) Upcoming Dividend Will Be Larger Than Last Year's

May 27
Amoy Diagnostics' (SZSE:300685) Upcoming Dividend Will Be Larger Than Last Year's

Earnings Report: Amoy Diagnostics Co., Ltd. Missed Revenue Estimates By 6.1%

Apr 24
Earnings Report: Amoy Diagnostics Co., Ltd. Missed Revenue Estimates By 6.1%

Amoy Diagnostics (SZSE:300685) Could Easily Take On More Debt

Apr 18
Amoy Diagnostics (SZSE:300685) Could Easily Take On More Debt

What Amoy Diagnostics Co., Ltd.'s (SZSE:300685) 33% Share Price Gain Is Not Telling You

Mar 02
What Amoy Diagnostics Co., Ltd.'s (SZSE:300685) 33% Share Price Gain Is Not Telling You

Is Amoy Diagnostics Co., Ltd. (SZSE:300685) Worth CN¥22.0 Based On Its Intrinsic Value?

Mar 01
Is Amoy Diagnostics Co., Ltd. (SZSE:300685) Worth CN¥22.0 Based On Its Intrinsic Value?

CEO

Jiemin Luo (41 yo)

13yrs

Tenure

CN¥676,500

Compensation

Mr. Jiemin Luo has been General Manager of Amoy Diagnostics Co., Ltd. and served its Deputy General Manager and Secretary of The Board of Directors since January 2012. He has been Non-Independent Director...


Leadership Team

NamePositionTenureCompensationOwnership
Ying Chen
CFO, Accounting Supervisor & Secretary to the Board of Directors9.7yrsCN¥872.70k0.039%
CN¥ 3.4m
Ruan Li
Deputy GM16.4yrsCN¥872.70k0.039%
CN¥ 3.4m
Frank Ron Zheng
Deputy GM & Director3.4yrsCN¥802.30kno data
Huibin Zheng
Deputy General Managerno dataCN¥694.40k0.039%
CN¥ 3.4m
Jiemin Luo
GM & Director13yrsCN¥676.50k0.039%
CN¥ 3.4m
Fei Luo
Deputy GM & Director15.4yrsCN¥755.80kno data

13.0yrs

Average Tenure

46yo

Average Age

Experienced Management: 300685's management team is seasoned and experienced (13 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Ruan Li
Deputy GM1.9yrsCN¥872.70k0.039%
CN¥ 3.4m
Frank Ron Zheng
Deputy GM & Director3.4yrsCN¥802.30kno data
Jiemin Luo
GM & Director3.4yrsCN¥676.50k0.039%
CN¥ 3.4m
Fei Luo
Deputy GM & Director15.4yrsCN¥755.80kno data
Li-Mou Zheng
Chairman16.9yrsCN¥490.30kno data
Hongyu Wang
Chairman of Supervisory Board9.6yrsno datano data
Xin Huang
Non-Independent Director3.4yrsno datano data
Wenjin Su
Independent Director3.4yrsno datano data
Enhua Wang
Independent Director3.4yrsCN¥112.70kno data
Qi Du
Non-Employee Supervisor3.4yrsno datano data
Zhe Shen
Independent Directorless than a yearno datano data
Qiao Wu
Independent Directorless than a yearno datano data

3.4yrs

Average Tenure

57yo

Average Age

Experienced Board: 300685's board of directors are considered experienced (3.4 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/07 02:13
End of Day Share Price 2025/01/07 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Amoy Diagnostics Co., Ltd. is covered by 16 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yolanda YinChina Galaxy International Securities (Hong Kong)
Pei ChengChina Galaxy Securities Co., Ltd.
Jin ZhangChina International Capital Corporation Limited